Anti-sickling agents
    5.
    发明申请
    Anti-sickling agents 有权
    防蛀剂

    公开(公告)号:US20050209199A1

    公开(公告)日:2005-09-22

    申请号:US11078690

    申请日:2005-03-14

    CPC分类号: C07D307/46 C07D417/04

    摘要: Compounds for the treatment of sickle-cell disease, and methods for their use are provided. The compounds have a dual mode of action. First, binding of the compounds to hemoglobin increases the oxygen affinity of both normal and sickle hemoglobin. Secondly, binding of these compounds to the N-terminal amino acid of sickle hemoglobin results in destabilization of potential contacts between sickle hemoglobin molecules, preventing polymerization and the formation of fibrous precipitates of the sickle hemoglobin. The compounds are also useful for inducing hypoxia, e.g. to augment cancer treatments.

    摘要翻译: 提供了治疗镰状细胞病的化合物及其使用方法。 这些化合物具有双重作用模式。 首先,化合物与血红蛋白的结合增加了正常和镰状血红蛋白的氧亲和力。 其次,这些化合物与镰刀血红蛋白的N-末端氨基酸的结合导致镰刀血红蛋白分子之间的潜在接触不稳定,防止聚合和镰状血红蛋白的纤维沉淀物的形成。 这些化合物也可用于诱导缺氧,例如, 增加癌症治疗。